Author Archives: Anna Andersen
Moving from Digitalization to Digitization in Cardiovascular Care
Why Is It Important, and What Could It Mean for Patients and Providers? “We are now at the cusp of the digital age of medicine – a time when pertinent data, previously locked away in a handwritten medical record or paper logbook, can be collected, aggregated, and analyzed at virtually the speed of light, and
How consumers and physicians view new medical technology
Researchers at STSI publish results of online comparative survey There is no denying that the digital revolution has (finally) arrived in medicine. New tools from genome sequencing to commercially accessible mobile health technologies are challenging the status quo, and ushering in a new era of digital medicine. Services once confined to the doctor’s office, are
The Doctor Paradox
Rediscovering Passion in Healthcare The Scripps Translational Science Institute (STSI) harbors many talented individuals with a broad range of skills – Dr. Paddy Barrett is one of them. Dr. Barrett is a trained Interventional Cardiologist working in digital medicine, as well as a KL2 Scholar at STSI. His latest project, the Doctor Paradox podcast, launched
Health Care Goes High-Tech
Dr. Eric Topol is featured on the cover of San Diego Magazine In an article published in the October 2015 issue of San Diego Magazine, STSI’s Director, Dr. Eric Topol discusses digital health, genomics, patient empowerment, and how San Diego is the most exciting place in the world for him. Read full article “Eric Topol
Test-driving a career in genomics, biostatistics and mHealth
STSI welcomes the next generation of translational science researchers Internships have long been part of the quintessential college experience. Every summer, offices and labs across the country experience an influx in young talent, eager to hone their skills and gather new knowledge. Summer internships provide students with useful hands-on training in a professional environment, and
How Genome Sequencing Creates Communities Around Rare Disorders
Following up with Lilly Grossman, the IDIOM study’s first volunteer In an article published in The Atlantic on September 21, 2015, staff writer Ed Yong follows up with Lilly Grossman, the first volunteer in the Scripps Translational Science Institute’s Idiopathic Diseases of Man (IDIOM) study, two years after first interviewing her and her family. Since
New leadership announced at The Scripps Research Institute
The Scripps Research Institute (TSRI) has announced the appointment of chemist Peter G. Schultz as CEO and biologist Steve A. Kay as President. Dr. Shultz is Professor of Chemistry at TSRI and Director of the California Institute for Biomedical Research. Dr. Kay, a former member of the TSRI faculty, will join from the University of
Don’t Delay News of Medical Breakthroughs
In a New York Times Op-Ed published on September 17, 2015, STSI’s Director Dr. Eric Topol and Yale cardiologist and health care researcher Dr. Harlan Krumholz call for the medical community to change how news of medical breakthroughs is communicated to the public. “Don’t Delay News of Medical Breakthroughs” discusses the recent decision by the
Remote sensing of vital signs – Protecting health care workers from deadly pathogens
How a wearable wireless sensor and personalized analytics could revolutionize vital sign monitoring in Ebola Treatment Units Throughout the West African Ebola outbreak, health care workers have been at the forefront of the battle to save lives and end the spread of the disease. An estimated 881 health care workers have contracted Ebola in Guinea,
Unpatients – why patients should own their own medical data
For the benefits of digital medicine to be fully realized, we need not only to find a shared home for personal health data but also to give individuals the right to own them. In a commentary published on September 8, 2015, in Nature Biotechnology, Dr. Eric Topol of Scripps Translational Science Institute, and Leonard Kish